| Name | Title | Contact Details |
|---|
For 32 years LA & SF Specialty has carefully curated fine ingredients and the most unique, seasonally ripe, locally grown produce for our discerning customers in Los Angeles, San Francisco, Orange County, San Diego, Phoenix and Las Vegas.
Clements Foods Company is a leading manufacturer of premium quality branded and private label food products. They are headquartered in Oklahoma City and distribute their products to leading retailers, wholesalers, and foodservice distributors throughou...
John Morrell and Co is one of the leading companies in the Manufacturing sector.
Feel the difference with our natural great tasting drinks obsessively formulated to help you feel good and perform better.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.